Companies: 10,795·Total market cap: $144.5T
The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOINASDAQHealthcare● Active
$5.07
+$0.20(+4.11%)
Market Cap$506913303
P/E Ratio
52W High$5.575
52W Low$2.015
Overview

The Oncology Institute, Inc.(TOI)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · TOI · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.50B$0.39B$0.32B$0.25B$0.20B
Cost of Revenue$0.43B$0.34B$0.26B$0.20B$0.16B
Gross Profit$0.08B$0.05B$0.06B$0.05B$0.04B
Gross Margin %(computed)15.20%13.73%18.37%20.63%20.12%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.11B$0.11B$0.14B$0.13B$0.09B
Operating Income($0.04B)($0.06B)($0.08B)($0.08B)($0.05B)
Operating Margin %(computed)-7.18%-15.28%-23.75%-32.46%-22.59%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.00B$0.00B
Income Before Tax($0.06B)($0.06B)($0.08B)($0.00B)($0.01B)
Income Tax Expense($0.00B)$0.00B($0.00B)($0.00B)($0.00B)
Net Income($0.06B)($0.06B)($0.08B)$0.00B($0.01B)
Net Margin %(computed)-12.06%-16.44%-25.62%0.06%-5.38%
Per Share & EBITDA
EPS (Basic)$-0.54$-0.71$-0.92$0.00$-0.16
Wtd Avg Shares0.92B0.08B0.07B0.07B0.07B
EBITDA($0.04B)($0.05B)($0.05B)($0.07B)($0.04B)
EBITDA Margin %(computed)-8.46%-13.68%-16.74%-26.77%-20.71%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解The Oncology Institute, Inc.

关于The Oncology Institute, Inc.(TOI)损益表

The Oncology Institute, Inc.(TOI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,TOI实现营收$0.50B,毛利润$0.08B(毛利率15.20%),净利润($0.06B)(净利率-12.06%)。

常见问题

TOI · 4 问

The Oncology Institute, Inc.(TOI)2025财年营收为$0.50B,同比up27.8%。

TOI revenueTOI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08